FR20C1014I1 - - Google Patents

Info

Publication number
FR20C1014I1
FR20C1014I1 FR20C1014C FR20C1014I1 FR 20C1014 I1 FR20C1014 I1 FR 20C1014I1 FR 20C1014 C FR20C1014 C FR 20C1014C FR 20C1014 I1 FR20C1014 I1 FR 20C1014I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37085728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR20C1014(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR20C1014I1 publication Critical patent/FR20C1014I1/fr
Application granted granted Critical
Publication of FR20C1014I2 publication Critical patent/FR20C1014I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
FR20C1014C 2005-06-08 2020-04-16 TREATMENT OF SLEEP-WAKE CYCLE DISORDERS Active FR20C1014I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68863805P 2005-06-08 2005-06-08
PCT/US2006/022407 WO2006133393A1 (en) 2005-06-08 2006-06-07 Treatment of sleep-wake disorders

Publications (2)

Publication Number Publication Date
FR20C1014I1 true FR20C1014I1 (en) 2020-06-12
FR20C1014I2 FR20C1014I2 (en) 2021-04-23

Family

ID=37085728

Family Applications (1)

Application Number Title Priority Date Filing Date
FR20C1014C Active FR20C1014I2 (en) 2005-06-08 2020-04-16 TREATMENT OF SLEEP-WAKE CYCLE DISORDERS

Country Status (16)

Country Link
US (6) US8440715B2 (en)
EP (1) EP1890684B1 (en)
JP (1) JP5024635B2 (en)
KR (1) KR101335941B1 (en)
CN (1) CN101217949B (en)
AU (1) AU2006254899B2 (en)
BR (1) BRPI0613697A2 (en)
CA (1) CA2611713C (en)
DK (1) DK1890684T3 (en)
ES (1) ES2435403T3 (en)
FR (1) FR20C1014I2 (en)
NL (1) NL301037I2 (en)
PL (1) PL1890684T3 (en)
RU (1) RU2417077C2 (en)
TW (2) TWI419681B (en)
WO (1) WO2006133393A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI419681B (en) 2005-06-08 2013-12-21 Sk Biopharmaceuticals Co Ltd Use of carbamate compounds for the manufacturing of a medicament for treating excessive daytime sleeping(eds)
EP1893291B1 (en) * 2005-06-22 2010-03-03 SK Holdings Co., Ltd. Treatment of sexual dysfunction
EP2445490B1 (en) 2009-06-22 2023-02-08 SK Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
RU2556585C2 (en) 2009-11-06 2015-07-10 Ск Биофармасъютиклс Ко., Лтд. Method of treating attention deficit/hyperactivity syndrome
CA2779442A1 (en) * 2009-11-06 2011-05-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) * 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
AU2014248849B2 (en) 2013-03-13 2018-08-30 Jazz Pharmaceuticals Ireland Limited Treatment of cataplexy
KR102309836B1 (en) * 2013-07-18 2021-10-12 에스케이바이오팜 주식회사 Treatment for obesity
TWI655179B (en) 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 Aminocarbonyl carbamate compound
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
WO2016061488A1 (en) 2014-10-17 2016-04-21 Concert Pharmaceuticals, Inc. Amine reuptake inhibitors
JP6466792B2 (en) * 2015-07-03 2019-02-06 エスケー バイオファーマスティカルズ カンパニー リミテッド Treatment of Attention Deficit / Hyperactivity Disorder (ADHD)
TWI637765B (en) * 2016-05-10 2018-10-11 台灣共振波研發股份有限公司 Soothing device for attention deficit hyperactivity disorder
US10195151B2 (en) * 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
EP3509582B1 (en) * 2016-09-06 2023-12-20 Axsome Malta Ltd. Solvate form of (r)-2-amino-3-phenylpropyl carbamate
US10710958B2 (en) 2016-10-06 2020-07-14 Jazz Pharmaceuticals Ireland Limited Carbamoyl phenylalaninol compounds and uses thereof
JP2020528075A (en) 2017-06-02 2020-09-17 ジャズ ファーマシューティカルズ アイルランド リミテッド Methods and Compositions for Treating Inability to Stay Awakening
RU2020108634A (en) * 2017-07-31 2021-09-02 Джаз Фармасьютикалз Айрлэнд Лимитед CARBAMOYLPHENYLALANINOL ANALOGUES AND METHODS OF THEIR APPLICATION
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
US11033214B1 (en) * 2020-05-19 2021-06-15 United Arab Emirates University Wearable eye tracking system
KR102390194B1 (en) 2020-08-03 2022-04-25 셀라이온바이오메드 주식회사 A composition for treating Kca3.1 channel mediated diseases comprising phenylalkyl carbamate compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2939660A1 (en) 1979-09-29 1981-04-16 Basf Ag, 6700 Ludwigshafen NEW CARBAMATES, THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM
NZ260667A (en) 1993-06-10 1997-05-26 Lilly Co Eli Preventing emesis or treating sexual dysfunction using tetrahydrobenz[cd]indole 6-carboxamides
KR100197892B1 (en) 1994-09-09 1999-06-15 남창우 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
KR0173862B1 (en) 1995-02-11 1999-04-01 조규향 O-carbamoyl- (D) -phenylalaninol compounds and their pharmaceutically useful salts and methods for their preparation
US5756817C1 (en) * 1995-02-11 2001-04-17 Sk Corp O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
KR0173863B1 (en) 1995-04-10 1999-04-01 조규향 O-carbamoyl-phenylalanineol compounds having substituents on phenyl, pharmaceutically useful salts thereof, and preparation methods thereof
EP0873308B1 (en) * 1996-10-10 2002-01-02 SK Corporation O-carbamoyl-phenylalaninol compounds and their pharmaceutically useful salts
WO1998017636A1 (en) 1996-10-22 1998-04-30 Ortho Pharmaceutical Corporation Phenylalaninol derivatives for the treatment of central nervous system disorders
KR100946944B1 (en) 2001-02-27 2010-03-15 오르토-맥네일 파마슈티칼, 인코퍼레이티드 Carbamate compounds for use in preventing or treating bipolar disorder
DK1411917T3 (en) 2001-02-27 2007-09-24 Ortho Mcneil Pharm Inc Carbamate compounds for use in the prevention or treatment of movement disorders
EP1399144B1 (en) 2001-02-27 2006-04-26 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
US20050080268A1 (en) 2003-10-08 2005-04-14 Yong-Moon Choi Process of preparing O-carbamoyl compounds in the presence of active amine group
US20050203130A1 (en) 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US8729120B2 (en) 2004-10-28 2014-05-20 Sk Biopharmaceuticals Co., Ltd. Adjunctive therapy for depression
TWI419681B (en) * 2005-06-08 2013-12-21 Sk Biopharmaceuticals Co Ltd Use of carbamate compounds for the manufacturing of a medicament for treating excessive daytime sleeping(eds)
EP1893291B1 (en) 2005-06-22 2010-03-03 SK Holdings Co., Ltd. Treatment of sexual dysfunction
EP1928451B1 (en) 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
CA2673487A1 (en) 2006-10-13 2008-04-24 Janssen Pharmaceutica Nv Phenylalkylamino carbamate compositions
EP2445490B1 (en) 2009-06-22 2023-02-08 SK Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
US8232315B2 (en) 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
RU2556585C2 (en) 2009-11-06 2015-07-10 Ск Биофармасъютиклс Ко., Лтд. Method of treating attention deficit/hyperactivity syndrome
CA2779442A1 (en) 2009-11-06 2011-05-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
KR102005483B1 (en) 2012-10-19 2019-07-31 삼성디스플레이 주식회사 Thin film transistor array panel and method for repairing the same
AU2014248849B2 (en) * 2013-03-13 2018-08-30 Jazz Pharmaceuticals Ireland Limited Treatment of cataplexy

Also Published As

Publication number Publication date
KR101335941B1 (en) 2013-12-04
BRPI0613697A2 (en) 2011-01-25
US8877806B2 (en) 2014-11-04
TW201328689A (en) 2013-07-16
JP5024635B2 (en) 2012-09-12
EP1890684A1 (en) 2008-02-27
NL301037I1 (en) 2020-04-01
DK1890684T3 (en) 2013-10-14
PL1890684T3 (en) 2014-05-30
US11753368B2 (en) 2023-09-12
JP2008545795A (en) 2008-12-18
US20130137764A1 (en) 2013-05-30
EP1890684B1 (en) 2013-08-14
RU2008100019A (en) 2009-07-20
KR20080035565A (en) 2008-04-23
RU2417077C2 (en) 2011-04-27
US10351517B2 (en) 2019-07-16
AU2006254899A1 (en) 2006-12-14
TWI419681B (en) 2013-12-21
US9604917B2 (en) 2017-03-28
US20190367448A1 (en) 2019-12-05
ES2435403T3 (en) 2013-12-19
CN101217949A (en) 2008-07-09
WO2006133393A1 (en) 2006-12-14
US20210078943A1 (en) 2021-03-18
US20170158622A1 (en) 2017-06-08
CN101217949B (en) 2012-10-17
US8440715B2 (en) 2013-05-14
US20090312416A1 (en) 2009-12-17
FR20C1014I2 (en) 2021-04-23
CA2611713C (en) 2013-10-01
CA2611713A1 (en) 2006-12-14
TW200716084A (en) 2007-05-01
NL301037I2 (en) 2020-05-12
US20140350098A1 (en) 2014-11-27
AU2006254899B2 (en) 2011-11-24

Similar Documents

Publication Publication Date Title
FR20C1014I1 (en)
JP2006048684A5 (en)
IN2008DE02606A (en)
JP2006207214A5 (en)
JP2006238635A5 (en)
JP2006223465A5 (en)
JP2007027563A5 (en)
JP2005304024A5 (en)
JP2007072371A5 (en)
JP2007011658A5 (en)
JP2006190606A5 (en)
JP2007031067A5 (en)
JP2006223740A5 (en)
CN300726695S (zh) 调料瓶套装(a)
CN300726008S (zh) 鞋帮
CN300905417S (zh) 壁扇底座(fw40-a7)
CN300726004S (zh) 鞋帮
CN300844489S (zh) 高尔夫球棒头
CN300728489S (zh) 水族馆(鱼缸)
CN300726699S (zh) 调料瓶套装(d)
CN300726698S (zh) 调料瓶套装(e)
CN300726697S (zh) 调料瓶套装(b)
CN300726696S (zh) 调料瓶套装(c)
CN300726005S (zh) 鞋帮
CN300726592S (zh) 碗用具（双壁式4）